KRP-AM1977X PhaseIII Clinical Study-Double blind comparative study for the patients with sinusitis

Kyorin Pharmaceutical Co.,LTD0 个研究点目标入组 279 人开始时间: 2015年5月25日最近更新: 2023年10月17日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方: Kyorin Pharmaceutical Co.,LTD
入组人数: 279

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The non-inferiority of KRP-AM1977X versus LVFX was demonstrated in the clinical efficacy rate at the end-of-treatment.In the safety assessment, no major problem was observed in KRP-AM1977X.

研究设计

研究类型: Interventional

入排标准

年龄范围: >= 16age old 至 <= 79age old（—）
性别: All

入选标准

•Sinusitis with clear infection symptoms

排除标准

•Sinusitis patient except Fungal Rhinosinusitis, eosinophilic sinusitis, etc.
•Patient with serious functional disorder that would unsuitable for the study
•Patient showing the tendency to improve sinusitis symptoms by other agents

研究者

发起方

Kyorin Pharmaceutical Co.,LTD

相似试验

已完成

3 期

KRP-AM1977X Phase III Comparative Study (Community acquired pneumonia)

JPRN-jRCT2080222860Kyorin Pharmaceutical Co.,LTD277

已完成

3 期

A Phase III, comparative study of KRP-AM1977Y in community- acquired pneumonia

JPRN-jRCT2080223246Kyorin Pharmaceutical Co.,LTD286

已完成

2 期

KRP-AM1977Y Phase II Clinical Study

JPRN-jRCT2080222567Kyorin Pharmaceutical Co.,LTD84

已完成

1 期

Phase I study of KRP-AM1977X (Clinical pharmacological study)Japanese healthy adult male subjects

JPRN-jRCT2080225163Kyorin Pharmaceutical Co., Ltd.54

已完成

3 期

KRP-AM1977X Phase III Open-label Study (Respiratory Tract Infection)Secondary infection of chronic respiratory disease and acute bronchitis

JPRN-jRCT2080222861Kyorin Pharmaceutical Co.,LTD53